王琳
副教授
学历/学位
博士
职称
副教授
电子邮箱
rushanwanglin@126.com
招生专业/类别
药学/学硕、专硕
一、基本情况
王琳,博士,副教授,rushanwanglin@126.com。
二、目前研究领域
药物代谢动力学
中药药效物质基础研究
三、学习及工作经历
中国药科大学药学院,本科
中国药科大学药学院,博士
烟台药物研究所,工程师
烟台大学,教师
四、主要科研成果
Qian F, Ouyang B1, Cai Z, Zhu D, Yu S, Zhao J, Wei N, Wang G,Wang L*, Zhang J*. Compound Shouwu Jiangzhi Granule regulates triacylglyceride synthesis to alleviate hepatic lipid accumulation. Phytomedicine. 2024 Jul;129:155691.
Su M, Liu X, Zhao Y, Zhu Y, Wu M, Liu K, Yang G, Liu W*, Wang L*. In Silico and In Vivo Pharmacokinetic Evaluation of 84-B10, a Novel Drug Candidate againstAcute Kidney Injury and Chronic Kidney Disease. Molecules. 2023 Dec 27;29(1):159.
Lin C, Kong Y, Wang F, Rong R, Li X, Xiao R, Wu Z, Zhang Q*, Wang L*. Design, synthesis and evaluation of a series of novel long-acting dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes. Bioorg Chem. 2022 Jun;123:105767.
Wang L, Li X, Kong Y, Wang F, Zhang Q, Lin C*, Rong R*. Pharmacokinetics, tissue distribution and excretion of compound 6c, a novel DPP-4 inhibitor, following intragastric administration in rats by ultra-performance liquid chromatography-tandem mass spectrometry. Eur J Pharm Sci. 2022 Jun 1;173:106162.
Wang L, Lei H, Lu J, Wang W, Liu C, WangY, YangY, Tian J*, Zhang J*. Study on Pharmacokinetics and Metabolic Profiles of Novel Potential PLK-1 Inhibitors by UHPLC-MS/MS Combined with UHPLC-Q-Orbitrap/HRMS. Molecules. 2023 Mar 10;28(6):2550.
指导研究生情况
已毕业 3 名,在读 3 名。